Los puntos clave no están disponibles para este artículo en este momento.
Despite the potential for residual axillary disease after SLND, SLND without ALND can offer excellent regional control and may be reasonable management for selected patients with early-stage breast cancer treated with breast-conserving therapy and adjuvant systemic therapy.
Giuliano et al. (Wed,) studied this question.